Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 147

1.

Reduction in Use of Risperidone for Dementia in Australia Following Changed Guidelines.

Kalisch Ellett LM, Moffat AK, Gadzhanova S, Pratt NL, Apajee J, Woodward M, Roughead EE.

Pharmacy (Basel). 2019 Jul 22;7(3). pii: E100. doi: 10.3390/pharmacy7030100.

2.

Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission.

Kalisch Ellett LM, Pratt NL, Apajee J, Roughead EE.

Int J Clin Pharm. 2019 Jun 25. doi: 10.1007/s11096-019-00866-8. [Epub ahead of print]

PMID:
31240552
3.

Prevalence and Duration of Use of Medicines Recommended for Short-Term Use in Aged Care Facility Residents.

Kalisch Ellett LM, Kassie GM, Pratt NL, Kerr M, Roughead EE.

Pharmacy (Basel). 2019 Jun 6;7(2). pii: E55. doi: 10.3390/pharmacy7020055.

4.

Consumer-directed technologies to improve medication management and safety.

Andrade AQ, Roughead EE.

Med J Aust. 2019 Apr;210 Suppl 6:S24-S27. doi: 10.5694/mja2.50029. No abstract available.

PMID:
30927471
5.

Use of Medicines that May Exacerbate Heart Failure in Older Adults: Therapeutic Complexity of Multimorbidity.

Caughey GE, Shakib S, Barratt JD, Roughead EE.

Drugs Aging. 2019 May;36(5):471-479. doi: 10.1007/s40266-019-00645-0.

PMID:
30875020
6.

Use of medicines that may precipitate delirium prior to hospitalisation in older Australians with delirium: An observational study.

Kassie GM, Kalisch Ellett LM, Nguyen TA, Roughead EE.

Australas J Ageing. 2019 Jun;38(2):124-131. doi: 10.1111/ajag.12608. Epub 2019 Jan 17.

PMID:
30656815
7.

Concomitant prescribing of opioids and benzodiazepines in Australia, 2012-2017.

Caughey GE, Gadzhanova S, Shakib S, Roughead EE.

Med J Aust. 2019 Jan;210(1):39-40. doi: 10.5694/mja2.12026. Epub 2018 Nov 8. No abstract available.

PMID:
30636298
8.

Using Post-market Utilisation Analysis to Support Medicines Pricing Policy: An Australian Case Study of Aflibercept and Ranibizumab Use.

Kemp-Casey A, Pratt N, Ramsay E, Roughead EE.

Appl Health Econ Health Policy. 2019 Jun;17(3):411-417. doi: 10.1007/s40258-018-0440-4.

PMID:
30362070
9.

Use of medicines and health services for chronic obstructive pulmonary disease among a cohort of Australians over 50 years.

Lim R, Kerr M, Roughead EE.

Int J Chron Obstruct Pulmon Dis. 2018 Oct 4;13:3085-3093. doi: 10.2147/COPD.S172495. eCollection 2018.

10.

Rehospitalizations for complications and mortality following pacemaker implantation: A retrospective cohort study in an older population.

Gillam MH, Pratt NL, Inacio MCS, Shakib S, Sanders P, Lau DH, Roughead EE.

Clin Cardiol. 2018 Nov;41(11):1480-1486. doi: 10.1002/clc.23091. Epub 2018 Oct 19.

11.

Comparative safety of NSAIDs for gastrointestinal events in Asia-Pacific populations: A multi-database, international cohort study.

Lai EC, Shin JY, Kubota K, Man KKC, Park BJ, Pratt N, Roughead EE, Wong ICK, Kao Yang YH, Setoguchi S.

Pharmacoepidemiol Drug Saf. 2018 Nov;27(11):1223-1230. doi: 10.1002/pds.4663. Epub 2018 Sep 19.

PMID:
30232832
12.

Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases.

Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad Ø, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegård A, Pratt NL, Roughead EE, Macias Saint-Gerons D, Stürmer T, Su CC, Zoega H, Sturkenbroom MCJM, Chan EW, Coghill D, Ip P, Wong ICK.

Lancet Psychiatry. 2018 Oct;5(10):824-835. doi: 10.1016/S2215-0366(18)30293-1. Epub 2018 Sep 13.

PMID:
30220514
13.

Effects of pharmacist prescribing on patient outcomes in the hospital setting: a systematic review.

Poh EW, McArthur A, Stephenson M, Roughead EE.

JBI Database System Rev Implement Rep. 2018 Sep;16(9):1823-1873. doi: 10.11124/JBISRIR-2017-003697.

PMID:
30204671
14.

Pricing policies for generic medicines in Australia, New Zealand, the Republic of Korea and Singapore: patent expiry and influence on atorvastatin price.

Roughead EE, Kim DS, Ong B, Kemp-Casey A.

WHO South East Asia J Public Health. 2018 Sep;7(2):99-106. doi: 10.4103/2224-3151.239421.

15.

Reducing hypnotic use in insomnia management among Australian veterans: results from repeated national interventions.

Kalisch Ellett LM, Lim R, Pratt NL, Kerr M, Ramsay EN, LeBlanc TV, Barratt JD, Roughead EE.

BMC Health Serv Res. 2018 Aug 9;18(1):626. doi: 10.1186/s12913-018-3443-9.

16.

Corruption practices in drug prescribing in Vietnam - an analysis based on qualitative interviews.

Nguyen TA, Knight R, Mant A, Razee H, Brooks G, Dang TH, Roughead EE.

BMC Health Serv Res. 2018 Jul 28;18(1):587. doi: 10.1186/s12913-018-3384-3.

17.

Mesh use in urogynaecological procedures between 2005 and 2016: An Australian cohort study.

Gillam MH, Kerr M, Pratt NL, Lim R, Roughead EE.

Aust N Z J Obstet Gynaecol. 2019 Feb;59(1):105-109. doi: 10.1111/ajo.12838. Epub 2018 Jun 21.

PMID:
29926904
18.
19.

Use of Potentially Inappropriate Medications in People With Dementia in Vietnam and Its Associated Factors.

Nguyen TA, Pham T, Vu HTT, Nguyen TX, Vu TT, Nguyen BTT, Nguyen NQ, Nguyen BT, Nguyen BT, Nguyen TN, Phan SV, Nguyen AT, Pham TL, Dang HT, Kalisch-Ellett L, Gillam M, Pratt N, Qiang S, Wang H, Kanjanarach T, Hassali MAA, Babar ZU, Razak AA, Chinwong D, Roughead EE.

Am J Alzheimers Dis Other Demen. 2018 Nov;33(7):423-432. doi: 10.1177/1533317518768999. Epub 2018 Apr 11.

PMID:
29642720
20.

Do Risk Prediction Models for Postoperative Delirium Consider Patients' Preoperative Medication Use?

Kassie GM, Nguyen TA, Kalisch Ellett LM, Pratt NL, Roughead EE.

Drugs Aging. 2018 Mar;35(3):213-222. doi: 10.1007/s40266-018-0526-6. Review.

PMID:
29423780

Supplemental Content

Loading ...
Support Center